skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 4,405  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy
Material Type:
Article
Add to My Research

Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy

European journal of heart failure, 2019-07, Vol.21 (7), p.827 [Peer Reviewed Journal]

ISSN: 1879-0844 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.1493

Digital Resources/Online E-Resources

2
Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF‐β/Smad signalling in type 2 diabetic rats
Material Type:
Article
Add to My Research

Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF‐β/Smad signalling in type 2 diabetic rats

Journal of cellular and molecular medicine, 2021-08, Vol.25 (16), p.7642-7659 [Peer Reviewed Journal]

2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16601 ;PMID: 34169635

Full text available

3
FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation
Material Type:
Article
Add to My Research

FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation

Journal of cellular and molecular medicine, 2015-07, Vol.19 (7), p.1557-1568 [Peer Reviewed Journal]

2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;Copyright © 2015 John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine ;2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. 2015 ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.12530 ;PMID: 25823710

Full text available

4
EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM
Material Type:
Article
Add to My Research

EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM

European journal of heart failure, 2014-05, Vol.16 (5), p.583-591 [Peer Reviewed Journal]

2014 The Authors. © 2014 European Society of Cardiology ;2014 The Authors. European Journal of Heart Failure © 2014 European Society of Cardiology. ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.68 ;PMID: 24591060

Full text available

5
Melatonin activates Parkin translocation and rescues the impaired mitophagy activity of diabetic cardiomyopathy through Mst1 inhibition
Material Type:
Article
Add to My Research

Melatonin activates Parkin translocation and rescues the impaired mitophagy activity of diabetic cardiomyopathy through Mst1 inhibition

Journal of cellular and molecular medicine, 2018-10, Vol.22 (10), p.5132-5144 [Peer Reviewed Journal]

2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.13802 ;PMID: 30063115

Full text available

6
Gypenosides improve diabetic cardiomyopathy by inhibiting ROS‐mediated NLRP3 inflammasome activation
Material Type:
Article
Add to My Research

Gypenosides improve diabetic cardiomyopathy by inhibiting ROS‐mediated NLRP3 inflammasome activation

Journal of cellular and molecular medicine, 2018-09, Vol.22 (9), p.4437-4448 [Peer Reviewed Journal]

2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.13743 ;PMID: 29993180

Full text available

7
Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model
Material Type:
Article
Add to My Research

Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model

Journal of cellular and molecular medicine, 2019-11, Vol.23 (11), p.7651-7663 [Peer Reviewed Journal]

2019 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2019 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14638 ;PMID: 31565849

Full text available

8
Glucagon‐like peptide‐1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARα pathway
Material Type:
Article
Add to My Research

Glucagon‐like peptide‐1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARα pathway

Aging cell, 2018-08, Vol.17 (4), p.e12763-n/a [Peer Reviewed Journal]

2018 The Authors. published by the Anatomical Society and John Wiley & Sons Ltd. ;2018 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd. ;Copyright © 2018 The Anatomical Society and John Wiley & Sons Ltd. ;ISSN: 1474-9718 ;EISSN: 1474-9726 ;DOI: 10.1111/acel.12763 ;PMID: 29659121

Full text available

9
Full Expression of Cardiomyopathy Is Partly Dependent on B‐Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis
Material Type:
Article
Add to My Research

Full Expression of Cardiomyopathy Is Partly Dependent on B‐Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis

Journal of the American Heart Association, 2016-01, Vol.5 (1), p.n/a [Peer Reviewed Journal]

2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.115.002484 ;PMID: 26769625

Full text available

10
Ginsenoside Rg1 ameliorates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress‐induced apoptosis in a streptozotocin‐induced diabetes rat model
Material Type:
Article
Add to My Research

Ginsenoside Rg1 ameliorates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress‐induced apoptosis in a streptozotocin‐induced diabetes rat model

Journal of cellular and molecular medicine, 2016-04, Vol.20 (4), p.623-631 [Peer Reviewed Journal]

2016 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;Copyright © 2016 Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine ;2016. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.12739 ;PMID: 26869403

Full text available

11
Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction
Material Type:
Article
Add to My Research

Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction

Journal of the American Heart Association, 2019-09, Vol.8 (17), p.e013114-e013114 [Peer Reviewed Journal]

2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.119.013114 ;PMID: 31431116

Full text available

12
Age‐dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria
Material Type:
Article
Add to My Research

Age‐dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria

Aging cell, 2010-08, Vol.9 (4), p.536-544 [Peer Reviewed Journal]

2010 The Authors. Journal compilation © Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland 2010 ;ISSN: 1474-9718 ;EISSN: 1474-9726 ;DOI: 10.1111/j.1474-9726.2010.00581.x ;PMID: 20456298

Digital Resources/Online E-Resources

13
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
Material Type:
Article
Add to My Research

Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy

European journal of heart failure, 2010-08, Vol.12 (8), p.767-778 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © 2010 the Authors ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1093/eurjhf/hfq120 ;PMID: 20675664

Full text available

14
Protective effects of spironolactone against anthracycline-induced cardiomyopathy
Material Type:
Article
Add to My Research

Protective effects of spironolactone against anthracycline-induced cardiomyopathy

European journal of heart failure, 2015-01, Vol.17 (1), p.81-89 [Peer Reviewed Journal]

2014 The Authors. © 2014 European Society of Cardiology ;2014 The Authors. European Journal of Heart Failure © 2014 European Society of Cardiology. ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.196 ;PMID: 25410653

Full text available

15
Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K/Akt pathway
Material Type:
Article
Add to My Research

Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K/Akt pathway

Journal of cellular and molecular medicine, 2019-08, Vol.23 (8), p.5349-5359 [Peer Reviewed Journal]

2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14413 ;PMID: 31131539

Full text available

16
4‐O‐methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK‐mediated cardiac lipid metabolism improvement
Material Type:
Article
Add to My Research

4‐O‐methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK‐mediated cardiac lipid metabolism improvement

Journal of cellular and molecular medicine, 2019-08, Vol.23 (8), p.5771-5781 [Peer Reviewed Journal]

2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14493 ;PMID: 31199069

Full text available

17
Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review
Material Type:
Article
Add to My Research

Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review

Journal of the American Heart Association, 2020-06, Vol.9 (11), p.e016704 [Peer Reviewed Journal]

2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.120.016704 ;PMID: 32468897

Full text available

18
Cardiomyopathy in obesity, insulin resistance and diabetes
Material Type:
Article
Add to My Research

Cardiomyopathy in obesity, insulin resistance and diabetes

The Journal of physiology, 2020-07, Vol.598 (14), p.2977-2993 [Peer Reviewed Journal]

2019 The Authors. The Journal of Physiology © 2019 The Physiological Society ;2019 The Authors. The Journal of Physiology © 2019 The Physiological Society. ;Journal compilation © 2020 The Physiological Society ;ISSN: 0022-3751 ;EISSN: 1469-7793 ;DOI: 10.1113/JP276747 ;PMID: 30869158

Full text available

19
Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway
Material Type:
Article
Add to My Research

Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway

Journal of cellular and molecular medicine, 2024-01, Vol.28 (2), p.e18055-n/a [Peer Reviewed Journal]

2023 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.18055 ;PMID: 38113341

Full text available

20
Sex-Related Differences in Genetic Cardiomyopathies
Material Type:
Article
Add to My Research

Sex-Related Differences in Genetic Cardiomyopathies

Journal of the American Heart Association, 2022-05, Vol.11 (9), p.e024947 [Peer Reviewed Journal]

2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.121.024947 ;PMID: 35470690

Full text available

Results 1 - 20 of 4,405  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (4,365)

Refine My Results

Creation Date 

From To
  1. Before 1987  (14)
  2. 1987 To 1995  (78)
  3. 1996 To 2004  (377)
  4. 2005 To 2014  (1,268)
  5. After 2014  (2,669)
  6. More options open sub menu

Resource Type 

  1. Articles  (4,379)
  2. Reports  (15)
  3. Book Chapters  (10)
  4. Conference Proceedings  (1)
  5. More options open sub menu

Language 

  1. English  (4,399)
  2. Japanese  (587)
  3. Norwegian  (11)
  4. German  (3)
  5. French  (2)
  6. More options open sub menu

Searching Remote Databases, Please Wait